Sarcoma  >>  Vigil (gemogenovatucel-T)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vigil (gemogenovatucel-T) / Gradalis
NCT03842865: Expanded Access of Vigil in Solid Tumors

Temporarily Not Available
N/A
US
Vigil, Engineered Autologous Tumor Cell Immunotherapy, FANG, IND 14205
Gradalis, Inc.
Solid Tumor, Ewing Sarcoma, Ewing's Tumor Metastatic, Ewing's Sarcoma Metastatic, Advanced Gynecological Cancers, Ovarian Cancer, Cervical Cancer, Uterine Cancer
 
 

Download Options